LeadCare® Ultra Blood Lead Test KitRecalls & reported problems
Magellan Diagnostics, Inc. · LeadCare® Ultra Blood Lead Test Kit · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
Quick summary
This Magellan LeadCare Ultra blood lead test kit is used to measure lead in blood. The 41 reports mostly describe low or inaccurate readings when samples are tested immediately instead of after sitting in the treatment reagent; there were no deaths or injuries. One open recall began in March 2026 because some third-party sample-collection devices were linked to unexpectedly high, potentially false-positive results.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 41
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 41 adverse event reports that list this exact device (DI 00850355006024), received between Dec 22, 2017 and Nov 22, 2019 — classified as 41 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (18 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Mar 13, 2026Class IIOpen, Classified
Customers reported observing unexpectedly elevated results when using certain third-party micro-collection devices to collect capillary samples for testing with the LeadCare Test Systems. False positive lead results may cause delayed results and additional unnecessary testing.
Z-1895-2026 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings18
- Low Test Results14
- False Negative Result9
Patient problems
- No Known Impact Or Consequence To Patient41
Recent adverse event reports
The 25 most recent of 41 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 22, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
SAMPLES TESTED IMMEDIATELY ON LEADCARE ULTRA AFTER PREPARATION IN TREATMENT REAGENT GIVE LOWER RESULTS THAN WHEN THE BLOOD/TREATMENT REAGENT MIXTURE WAS HELD FOR A PERIOD OF TIME BEFORE TESTING.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9365044 ↗MalfunctionNov 22, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
SAMPLES TESTED IMMEDIATELY ON LEADCARE ULTRA AFTER PREPARATION IN TREATMENT REAGENT GIVE LOWER RESULTS THAN WHEN THE BLOOD/TREATMENT REAGENT MIXTURE WAS HELD FOR A PERIOD OF TIME BEFORE TESTING.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9365035 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00040 ADDENDUM. SAMPLES TESTED WITH LEADCARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356628 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00040 ADDENDUM: SAMPLES TESTED WITH LEADCARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356625 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM. SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED). BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356624 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM: SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED). BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356622 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00035 ADDENDUM. CUSTOMER REPORTED SAMPLES TESTED IMMEDIATELY AFTER ADDITION TO TREATMENT REAGENT PRODUCE LOWER BLOOD LEAD VALUES THAN WHEN THEY ARE ALLOWED TO SIT FOR 1 HOUR, 24 HOURS, OR 72 HOURS IN THE TREATMENT REAGENT BEFORE TESTING.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356620 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00040 ADDENDUM: SAMPLES TESTED WITH LEADCARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356617 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM: SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED). BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356614 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00040 ADDENDUM: SAMPLES TESTED WITH LEADCARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356613 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM: SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED).BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356612 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
1218996-2017-00041 ADDENDUM BLOOD/TREATMENT REAGENT MIXTURES TESTED WITH LEADCARE ULTRA PRODUCE RESULTS AT TIME T=0 THAT ARE LOWER THAN WHEN THE MIXTURE IS HELD AND THEN TESTED AT T=24, AND T=48.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356610 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00040 ADDENDUM: SAMPLES TESTED WITH LEADCARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356609 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM: SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED). BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356607 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM: SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED). BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356605 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR#: 1218996-2017-00040 ADDENDUM. SAMPLES TESTED WITH LEAD CARE ULTRA PRODUCED RESULTS THAT WERE LOW WHEN COMPARED TO THE REFERENCE METHOD ICP/MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356602 ↗MalfunctionNov 21, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
128996-2017-00039 ADDENDUM. SAMPLES INITIALLY TESTED WITH LEADCARE ULTRA PRODUCED LOW TEST RESULTS WHEN COMPARED TO THE REFERENCE METHOD (UNSPECIFIED).BLOOD/TREATMENT REAGENT MIXTURES WERE SUBSEQUENTLY RETESTED FOLLOWING AN HOUR LONG INCUBATION. RESULTS FOLLOWING THE ONE-HOUR HOLD TIME WERE CLOSER TO THE REFERENCE VALUE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9356598 ↗MalfunctionOct 21, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM. CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9213357 ↗MalfunctionOct 4, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM. CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159270 ↗MalfunctionOct 4, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM: CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159268 ↗MalfunctionOct 4, 2019False Negative Result; False Negative Result
MDR 1218996-2017-00038 ADDENDUM: CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159267 ↗MalfunctionOct 4, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
MDR 1218996-2017-00036 ADDENDUM: SAMPLES TESTED IMMEDIATELY AFTER PREPARATION IN TREATMENT REAGENT PRODUCED LOWER BLOOD LEAD VALUES THAN WHEN THEY WERE HELD IN TREATMENT REAGENT FOR A PERIOD OF TIME BEFORE TESTING.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159265 ↗MalfunctionOct 4, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM: CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159264 ↗MalfunctionOct 4, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM: CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159263 ↗MalfunctionOct 4, 2019Low Test Results; Low Test Results
MDR 1218996-2017-00038 ADDENDUM: CUSTOMER REPORTED THAT RESULTS OF SAMPLES TESTED BY LEADCARE ULTRA WERE LOW COMPARED TO AN OLDER MODEL OF THE DEVICE AND ICP-MS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9159262 ↗
Other Lead, Atomic Absorption devices
- LeadCare® II Blood Lead Test KitMagellan Diagnostics, Inc. · Lead, Atomic Absorption4 recalls353 reports
- LeadCare® II Blood Lead Analyzer KitMagellan Diagnostics, Inc. · Lead, Atomic Absorption137 reports
- LeadCare® II Blood Lead Testing System 9X Test KitMagellan Diagnostics, Inc. · Lead, Atomic Absorption1 recall0 reports
- LeadCare® II 5X Test KitMagellan Diagnostics, Inc. · Lead, Atomic Absorption1 recall0 reports
- LeadCare® Plus Blood Lead Test KitMagellan Diagnostics, Inc. · Lead, Atomic Absorption1 recall0 reports
- LeadCare® II Blood Lead Analyzer Kit, RefurbishedMagellan Diagnostics, Inc. · Lead, Atomic Absorption21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page